Quick Answer
GALECTIN THERAPEUTICS INC reported Shares Outstanding of 65.20 million shares for fiscal year 2025.
GALECTIN THERAPEUTICS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 65.20M | +3.2% |
| 2024 | 63.16M | +2.1% |
| 2023 | 61.85M | +4.1% |
| 2022 | 59.43M | +0.1% |
| 2021 | 59.34M | +4.0% |
| 2020 | 57.08M | +0.3% |
| 2019 | 56.89M | +38.1% |
| 2018 | 41.19M | +15.1% |
| 2017 | 35.79M | +8.7% |
| 2016 | 32.91M | +14.2% |
| 2015 | 28.83M | +29.4% |
| 2014 | 22.28M | +21.2% |
| 2013 | 18.39M | +14.5% |
| 2012 | 16.06M | +24.3% |
| 2011 | 12.92M | +21.3% |
| 2010 | 10.65M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 64.47M | +3.5% | +0.6% |
| June 30, 2025 | 64.06M | +2.9% | +1.2% |
| March 31, 2025 | 63.29M | +1.8% | +0.2% |
| December 31, 2024 | 63.16M | +2.1% | +1.4% |
| September 30, 2024 | 62.31M | +0.7% | +0.0% |
| June 30, 2024 | 62.28M | +4.5% | +0.2% |
| March 31, 2024 | 62.15M | +4.3% | +0.5% |
| December 31, 2023 | 61.85M | +4.1% | +0.0% |
- GALECTIN THERAPEUTICS INC showed an increase of +3.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, GALECTIN THERAPEUTICS INC’s shares outstanding has grown by 512.1% (from 10.65 million shares to 65.20 million shares).
- The most recent figure is from GALECTIN THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: